This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Oneok Inc. (OKE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Oneok Inc. (OKE) closed the most recent trading day at $77.12, moving -0.68% from the previous trading session.
The Zacks Analyst Blog Highlights Novo Nordisk, Tesla, Airbnb, ONEOK and CDW
by Zacks Equity Research
Novo Nordisk, Tesla, Airbnb, ONEOK and CDW are part of the Zacks top Analyst Blog.
Top Research Reports for Novo Nordisk, Tesla & Airbnb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Tesla, Inc. (TSLA) and Airbnb, Inc. (ABNB).
ONEOK (OKE) Earnings and Revenues Miss Estimates in Q4
by Zacks Equity Research
ONEOK's (OKE) fourth-quarter earnings and revenues lag estimates. The company plans to make investments in the range of $1.75-$1.9 billion in 2024 to strengthen its operation.
Here's What Key Metrics Tell Us About Oneok (OKE) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Oneok (OKE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Oneok Inc. (OKE) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Oneok Inc. (OKE) reachead $73.72 at the closing of the latest trading day, reflecting a +0.53% change compared to its last close.
ONEOK (OKE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
ONEOK's (OKE) fourth-quarter earnings are likely to have gained from fee-based contracts and the completed acquisition of Magellan Midstream Partners.
Oneok Inc. (OKE) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oneok (OKE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights NIKE, Airbnb, CVS Health, ONEOK and Arch Capital
by Zacks Equity Research
NIKE, Airbnb, CVS Health, ONEOK and Arch Capital are included in this Analyst Blog.
Q4 Earnings Scorecard and Fresh Analyst Reports for Nike, Airbnb & CVS Health
by Sheraz Mian
Today's Research Daily features a real-time earnings season update and new research reports on NIKE (NKE), Airbnb (ABNB), CVS Health (CVS) and others.